TELA Bio sees 23-27% income development for 2025 with expanded gross sales technique (NASDAQ:TELA)

In search of Alpha’s Disclaimer: The earnings name insights are compilations of earnings name transcripts and different content material obtainable on the In search of Alpha web site. The insights are generated by an AI instrument and haven’t been curated or reviewed by editors. Resulting from inherent limitations in utilizing AI-based instruments, the accuracy, completeness, or timeliness of the earnings name insights can’t be assured. Please see full earnings name transcripts right here. The earnings name insights are meant for informational functions solely. In search of Alpha doesn’t take account of your goals or your monetary scenario and doesn’t supply any customized funding recommendation. In search of Alpha shouldn’t be a licensed securities supplier, dealer or US funding adviser or funding financial institution.